Literature DB >> 30107176

Integrated Genomic Analysis of Hürthle Cell Cancer Reveals Oncogenic Drivers, Recurrent Mitochondrial Mutations, and Unique Chromosomal Landscapes.

Ian Ganly1, Vladimir Makarov2, Shyamprasad Deraje3, YiYu Dong3, Ed Reznik4, Venkatraman Seshan5, Gouri Nanjangud6, Stephanie Eng3, Promita Bose3, Fengshen Kuo3, Luc G T Morris7, Inigo Landa3, Pedro Blecua Carrillo Albornoz2, Nadeem Riaz2, Yuri E Nikiforov8, Kepal Patel9, Christopher Umbricht10, Martha Zeiger10, Electron Kebebew11, Eric Sherman12, Ronald Ghossein13, James A Fagin3, Timothy A Chan14.   

Abstract

The molecular foundations of Hürthle cell carcinoma (HCC) are poorly understood. Here we describe a comprehensive genomic characterization of 56 primary HCC tumors that span the spectrum of tumor behavior. We elucidate the mutational profile and driver mutations and show that these tumors exhibit a wide range of recurrent mutations. Notably, we report a high number of disruptive mutations to both protein-coding and tRNA-encoding regions of the mitochondrial genome. We reveal unique chromosomal landscapes that involve whole-chromosomal duplications of chromosomes 5 and 7 and widespread loss of heterozygosity arising from haploidization and copy-number-neutral uniparental disomy. We also identify fusion genes and disrupted signaling pathways that may drive disease pathogenesis.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hurthle cell carcinoma; copy-number alterations; fusion genes; genomics; mitochondrial mutations; transcriptome

Mesh:

Substances:

Year:  2018        PMID: 30107176      PMCID: PMC6247912          DOI: 10.1016/j.ccell.2018.07.002

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  67 in total

Review 1.  Pathogenesis and consequences of uniparental disomy in cancer.

Authors:  Hideki Makishima; Jaroslaw P Maciejewski
Journal:  Clin Cancer Res       Date:  2011-04-25       Impact factor: 12.531

2.  Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.

Authors:  Iñigo Landa; Tihana Ibrahimpasic; Laura Boucai; Rileen Sinha; Jeffrey A Knauf; Ronak H Shah; Snjezana Dogan; Julio C Ricarte-Filho; Gnana P Krishnamoorthy; Bin Xu; Nikolaus Schultz; Michael F Berger; Chris Sander; Barry S Taylor; Ronald Ghossein; Ian Ganly; James A Fagin
Journal:  J Clin Invest       Date:  2016-02-15       Impact factor: 14.808

Review 3.  Targeting RAS-ERK signalling in cancer: promises and challenges.

Authors:  Ahmed A Samatar; Poulikos I Poulikakos
Journal:  Nat Rev Drug Discov       Date:  2014-12       Impact factor: 84.694

4.  Specific correlation between the wobble modification deficiency in mutant tRNAs and the clinical features of a human mitochondrial disease.

Authors:  Yohei Kirino; Yu-Ichi Goto; Yolanda Campos; Joaquin Arenas; Tsutomu Suzuki
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-03       Impact factor: 11.205

5.  Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.

Authors:  Luis Lopez-Penabad; Alice C Chiu; Ana O Hoff; Pamela Schultz; Sonia Gaztambide; Nelson G Ordoñez; Steven I Sherman
Journal:  Cancer       Date:  2003-03-01       Impact factor: 6.860

6.  TERT promoter mutations in familial and sporadic melanoma.

Authors:  Susanne Horn; Adina Figl; P Sivaramakrishna Rachakonda; Christine Fischer; Antje Sucker; Andreas Gast; Stephanie Kadel; Iris Moll; Eduardo Nagore; Kari Hemminki; Dirk Schadendorf; Rajiv Kumar
Journal:  Science       Date:  2013-01-24       Impact factor: 47.728

7.  A mitochondrial tRNA(His) gene mutation causing pigmentary retinopathy and neurosensorial deafness.

Authors:  M Crimi; S Galbiati; M P Perini; A Bordoni; G Malferrari; M Sciacco; I Biunno; S Strazzer; M Moggio; N Bresolin; G P Comi
Journal:  Neurology       Date:  2003-04-08       Impact factor: 9.910

8.  Comprehensive molecular characterization of human colon and rectal cancer.

Authors: 
Journal:  Nature       Date:  2012-07-18       Impact factor: 49.962

9.  Integrated genomic analyses of ovarian carcinoma.

Authors: 
Journal:  Nature       Date:  2011-06-29       Impact factor: 49.962

10.  Comprehensive molecular portraits of human breast tumours.

Authors: 
Journal:  Nature       Date:  2012-09-23       Impact factor: 49.962

View more
  60 in total

1.  Afirma Gene Sequencing Classifier Compared with Gene Expression Classifier in Indeterminate Thyroid Nodules.

Authors:  Mayumi Endo; Fadi Nabhan; Kyle Porter; Katie Roll; Lawrence A Shirley; Irina Azaryan; Dena Tonkovich; Jeanette Perlick; Laura E Ryan; Raheela Khawaja; Shumei Meng; John E Phay; Matthew D Ringel; Jennifer A Sipos
Journal:  Thyroid       Date:  2019-07-17       Impact factor: 6.568

Review 2.  Microbiota-Propelled T Helper 17 Cells in Inflammatory Diseases and Cancer.

Authors:  Matteo Bellone; Arianna Brevi; Samuel Huber
Journal:  Microbiol Mol Biol Rev       Date:  2020-03-04       Impact factor: 11.056

3.  Foundation One Genomic Interrogation of Thyroid Cancers in Patients With Metastatic Disease Requiring Systemic Therapy.

Authors:  Nicole M Iñiguez-Ariza; Sina Jasim; Mabel M Ryder; Ashish V Chintakuntlawar; John C Morris; Crystal R Hilger; Michael E Menefee; Robert C Smallridge; Nina J Karlin; Constanza Alcaino; Keith C Bible
Journal:  J Clin Endocrinol Metab       Date:  2020-07-01       Impact factor: 5.958

Review 4.  Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): Diagnostic updates and molecular advances.

Authors:  Ying-Hsia Chu; Peter M Sadow
Journal:  Semin Diagn Pathol       Date:  2020-06-10       Impact factor: 3.464

Review 5.  Current practice in patients with differentiated thyroid cancer.

Authors:  Martin Schlumberger; Sophie Leboulleux
Journal:  Nat Rev Endocrinol       Date:  2020-12-18       Impact factor: 43.330

6.  Hürthle cell hurdles: Why do tumors derived from this cell type refuse to reveal their secrets and weaknesses?

Authors:  Peter M Sadow
Journal:  Cancer Cytopathol       Date:  2020-10-12       Impact factor: 5.284

7.  Outcome and molecular characteristics of non-invasive encapsulated follicular variant of papillary thyroid carcinoma with oncocytic features.

Authors:  Bin Xu; Ed Reznik; R Michael Tuttle; Jeffrey Knauf; James A Fagin; Nora Katabi; Snjezana Dogan; Nathaniel Aleynick; Venkatraman Seshan; Sumit Middha; Danny Enepekides; Gian Piero Casadei; Erica Solaroli; Giovanni Tallini; Ronald Ghossein; Ian Ganly
Journal:  Endocrine       Date:  2019-01-28       Impact factor: 3.633

Review 8.  Progression and dormancy in metastatic thyroid cancer: concepts and clinical implications.

Authors:  Neel Rajan; Tilak Khanal; Matthew D Ringel
Journal:  Endocrine       Date:  2020-08-11       Impact factor: 3.633

Review 9.  Molecular Alterations in Thyroid Carcinoma.

Authors:  Mohamed Rizwan Haroon Al Rasheed; Bin Xu
Journal:  Surg Pathol Clin       Date:  2019-09-27

10.  Molecular characterization of localized pleural mesothelioma.

Authors:  Yin P Hung; Fei Dong; Adrian M Dubuc; Paola Dal Cin; Raphael Bueno; Lucian R Chirieac
Journal:  Mod Pathol       Date:  2019-08-01       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.